{
    "cluster": 0,
    "subcluster": 0,
    "abstract_summ": "Further study with COVID-19 testing is required to identify the proportion of patients in whom new onset anosmia can be attributed to COVID-19.BACKGROUND Anosmia and dysgeusia have been reported as potential symptoms of coronavirus disease 2019.The objective was to characterise patients reporting new onset anosmia during the COVID-19 pandemic METHODOLOGY: Design: Survey of 2428 patients reporting new onset anosmia during the COVID-19 pandemic.Background: This systematic review had three aims: i) to determine the frequency of anosmia (or other smell disorders) and dysgeusia (or other taste disorders) in COVID-19 patients; ii) to determine whether anosmia or dysgeusia are independently associated with COVID-19 diagnosis; and iii) to determine whether anosmia or dysgeusia are prognostic factors for impaired outcomes among COVID-19 patients.The purpose of this report was to summarise the evidence on the existence of anosmia and ageusia an emerging COVID-19 symptoms in order to better inform both oncology patients and clinicians.Whilst more data is currently needed to strengthen our knowledge of the symptoms of COVID-19, oncology patients who are concerned about anosmia or ageusia in the context of their systemic anti-cancer therapy should contact their acute oncology support line for advice.",
    "title_summ": "COVID-19 presenting as anosmia and dysgeusia in New York City emergency departments, March - April, 2020Anosmia in COVID-19 patientsCOVID-19 and Anosmia in Tehran, IranCOVID-19 in otolaryngologist practice: a review of current knowledgeCOVID-19 and anosmia: A review based on up-to-date knowledgeAnosmia and dysgeusia in COVID-19: A systematic reviewNew onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2ANOSMIA - A REVIEW: IN THE CONTEXT OF COVID 19/OROFACIAL PAINFeatures of anosmia in COVID-19Self-reported anosmia and dysgeusia as key symptoms of coronavirus disease 2019Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?Anosmia and dysgeusia associated with SARS-CoV-2 infection: an age-matched case-control study.Anosmia and the Need for COVID-19 Screening during the Pandemic.Presentation of new onset anosmia during the COVID-19 pandemic.COVID-19 Anosmia Reporting Tool: Initial Findings.",
    "title_abstract_phrases": "The objective was to characterise patients reporting new onset anosmia during the COVID-19 pandemic METHODOLOGY: Design: Survey of 2428 patients reporting new onset anosmia during the COVID-19 pandemic.Methods: We retrospectively included COVID-19 patients with anosmia between March 1 and March 17, 2020.The purpose of this report was to summarise the evidence on the existence of anosmia and ageusia an emerging COVID-19 symptoms in order to better inform both oncology patients and clinicians.Whilst more data is currently needed to strengthen our knowledge of the symptoms of COVID-19, oncology patients who are concerned about anosmia or ageusia in the context of their systemic anti-cancer therapy should contact their acute oncology support line for advice.Anosmia in COVID-19 patientsObjectives: Coronaviruses (CoVs) have a neuroinvasive propensity, and the frequently reported symptoms of smelling and taste dysfunction in many COVID-19 patients may be related to the respective capability of SARS-CoV2, the cause of the current pandemic."
}